Summary of Significant Accounting Policies (Tables)
|
6 Months Ended |
12 Months Ended |
Jun. 30, 2024 |
Dec. 31, 2023 |
| Accounting Policies [Abstract] |
|
|
| Schedule of Basic and Diluted Net Loss Per Share |
The
calculation of basic and diluted net loss per share attributable to common stock was as follows:
Schedule
of Basic and Diluted Net Loss Per Share
| | |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| | |
For
the Three Months Ended
June 30, | | |
For
the Six Months Ended
June 30, | |
| | |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| Numerator: | |
| | | |
| | | |
| | | |
| | |
| Net loss attributable to common stock—basic and diluted | |
$ | (4,165,108 | ) | |
$ | (3,486,053 | ) | |
$ | (8,665,380 | ) | |
$ | (7,251,175 | ) |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted average shares—basic and diluted | |
| 541,836 | | |
| 129,193 | | |
| 444,474 | | |
| 129,127 | |
| Net loss per share attributable to common stock—basic and diluted | |
$ | (7.69 | ) | |
$ | (26.98 | ) | |
$ | (19.50 | ) | |
$ | (56.16 | ) |
|
The
calculation of basic and diluted net loss per share attributable to common stock was as follows:
Schedule of Basic and Diluted Net Loss Per Share
| | |
2023 | | |
2022 | |
| | |
As of December 31, | |
| | |
2023 | | |
2022 | |
| Numerator: | |
| | | |
| | |
| Net loss attributable to common stock-basic and diluted | |
$ | (14,406,262 | ) | |
$ | (15,468,502 | ) |
| Denominator: | |
| | | |
| | |
| Weighted average shares-basic and diluted | |
| 137,074 | | |
| 128,822 | |
| Net loss per share attributable to common stock-basic and diluted | |
$ | (105.10 | ) | |
$ | (111.83 | ) |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
Securities
that were excluded from loss per share as their effect would be anti-dilutive due to the net loss position that could potentially be
dilutive in future periods are as follows:
Schedule
of Antidilutive Securities Excluded from Computation of Earnings Per Share
| | |
2024 | | |
2023 | |
| | |
As of June 30, | |
| | |
2024 | | |
2023 | |
| Options | |
| 33,649 | | |
| 13,405 | |
| RSUs | |
| 17,558 | | |
| — | |
| Public warrants | |
| 230,000 | | |
| — | |
| GEM warrants | |
| 16,571 | | |
| — | |
| Common warrants | |
| 277,778 | | |
| — | |
| Placement agent warrants | |
| 16,667 | | |
| — | |
| Total | |
| 592,222 | | |
| 13,405 | |
| Antidilutive Securities | |
| 592,222 | | |
| 13,405 | |
|
Securities
that were excluded from loss per share as their effect would be anti-dilutive due to the net loss position that could potentially be
dilutive in future periods are as follows:
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
| | |
2023 | | |
2022 | |
| | |
As of December 31, | |
| | |
2023 | | |
2022 | |
| Options | |
| 14,962 | | |
| 7,420 | |
| Public warrants | |
| 230,000 | | |
| - | |
| GEM warrants | |
| 16,571 | | |
| - | |
| Total | |
| 261,533 | | |
| 7,420 | |
| Antidilutive Securities | |
| 261,533 | | |
| 7,420 | |
|
| Summary of Changes in Allowance for Credit Losses |
|
The
following table presents changes in the allowance for credit losses for the year ended December 31, 2023:
Summary of Changes in Allowance for Credit Losses
| | |
| | |
| Balance-January 1, 2023 | |
$ | 107,860 | |
| Change in provision for credit losses | |
| (102,112 | ) |
| Balance-December 31, 2023 | |
$ | 5,748 | |
|
| Summary of Capitalized Deferred Offering Costs |
|
Capitalized
deferred offering costs consisted of the following, as of December 14, 2023 and December 31, 2022:
Summary of Capitalized Deferred Offering Costs
| | |
December 14,
2023 | | |
December 31,
2022 | |
| SPAC-related legal fees | |
$ | 2,973,077 | | |
$ | 1,264,914 | |
| Investment bank advisory services | |
| 135,000 | | |
| 135,000 | |
| Federal Trade Commission filing fees | |
| 125,020 | | |
| 125,020 | |
| Total deferred offering costs capitalized | |
$ | 3,233,097 | | |
$ | 1,524,934 | |
|